Viral drug resistance through 48 weeks, in a phase 2b, randomized, controlled trial of the HIV-1 attachment inhibitor prodrug, fostemsavir
Journal of Acquired Immune Deficiency Syndromes | Feb 15, 2018
Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort
Journal of Neurology, Neurosurgery & Psychiatry | Feb 15, 2018
Most read this week